Annual D&A
$2.61 M
+$32.00 K+1.24%
31 December 2023
Summary:
Evogene annual depreciation & amortization is currently $2.61 million, with the most recent change of +$32.00 thousand (+1.24%) on 31 December 2023. During the last 3 years, it has fallen by -$115.00 thousand (-4.22%). EVGN annual D&A is now -5.67% below its all-time high of $2.77 million, reached on 31 December 2019.EVGN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$627.00 K
+$14.00 K+2.28%
30 September 2024
Summary:
Evogene quarterly depreciation & amortization is currently $627.00 thousand, with the most recent change of +$14.00 thousand (+2.28%) on 30 September 2024. Over the past year, it has dropped by -$34.00 thousand (-5.14%). EVGN quarterly D&A is now -20.13% below its all-time high of $785.00 thousand, reached on 30 September 2019.EVGN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.57 M
-$34.00 K-1.30%
30 September 2024
Summary:
Evogene TTM depreciation & amortization is currently $2.57 million, with the most recent change of -$34.00 thousand (-1.30%) on 30 September 2024. Over the past year, it has dropped by -$16.00 thousand (-0.62%). EVGN TTM D&A is now -9.21% below its all-time high of $2.83 million, reached on 30 June 2020.EVGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | -5.1% | -0.6% |
| 3 y3 years | -4.2% | +14.4% | +11.5% |
| 5 y5 years | +29.3% | -20.1% | -1.5% |
EVGN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.2% | +16.9% | -7.9% | +14.4% | -2.6% | +15.2% |
| 5 y | 5 years | -5.7% | +29.3% | -20.1% | +14.4% | -9.2% | +15.2% |
| alltime | all time | -5.7% | +84.1% | -20.1% | +26.4% | -9.2% | +408.7% |
Evogene Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $627.00 K(+2.3%) | $2.57 M(-1.3%) |
| June 2024 | - | $613.00 K(-8.6%) | $2.61 M(-1.3%) |
| Mar 2024 | - | $671.00 K(+1.2%) | $2.64 M(+1.1%) |
| Dec 2023 | $2.61 M(+1.2%) | $663.00 K(+0.3%) | $2.61 M(+0.8%) |
| Sept 2023 | - | $661.00 K(+2.2%) | $2.59 M(+0.6%) |
| June 2023 | - | $647.00 K(+0.9%) | $2.57 M(+1.3%) |
| Mar 2023 | - | $641.00 K(0.0%) | $2.54 M(-1.6%) |
| Dec 2022 | $2.58 M(+15.5%) | $641.00 K(-0.6%) | $2.58 M(+3.6%) |
| Sept 2022 | - | $645.00 K(+5.2%) | $2.49 M(+4.1%) |
| June 2022 | - | $613.00 K(-10.0%) | $2.39 M(+1.7%) |
| Mar 2022 | - | $681.00 K(+23.4%) | $2.35 M(+5.4%) |
| Dec 2021 | $2.23 M(-18.1%) | $552.00 K(+0.7%) | $2.23 M(-3.2%) |
| Sept 2021 | - | $548.00 K(-4.5%) | $2.31 M(-6.9%) |
| June 2021 | - | $574.00 K(+2.5%) | $2.48 M(-5.8%) |
| Mar 2021 | - | $560.00 K(-10.7%) | $2.63 M(-3.4%) |
| Dec 2020 | $2.73 M(-1.5%) | $627.00 K(-12.8%) | $2.73 M(-1.5%) |
| Sept 2020 | - | $719.00 K(-1.2%) | $2.77 M(-2.3%) |
| June 2020 | - | $728.00 K(+11.5%) | $2.83 M(+1.8%) |
| Mar 2020 | - | $653.00 K(-2.4%) | $2.78 M(+0.5%) |
| Dec 2019 | $2.77 M(+37.1%) | $669.00 K(-14.8%) | $2.77 M(+6.0%) |
| Sept 2019 | - | $785.00 K(+16.0%) | $2.61 M(+12.0%) |
| June 2019 | - | $677.00 K(+6.1%) | $2.33 M(+8.0%) |
| Mar 2019 | - | $638.00 K(+24.4%) | $2.16 M(+7.0%) |
| Dec 2018 | $2.02 M | $513.00 K(+1.4%) | $2.02 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $506.00 K(+0.2%) | $2.03 M(-1.3%) |
| June 2018 | - | $505.00 K(+1.8%) | $2.06 M(-2.0%) |
| Mar 2018 | - | $496.00 K(-4.8%) | $2.10 M(-2.3%) |
| Dec 2017 | $2.15 M(-5.9%) | $521.00 K(-2.3%) | $2.15 M(+0.2%) |
| Sept 2017 | - | $533.00 K(-2.4%) | $2.14 M(-2.5%) |
| June 2017 | - | $546.00 K(+0.2%) | $2.19 M(-1.7%) |
| Mar 2017 | - | $545.00 K(+5.6%) | $2.23 M(-2.0%) |
| Dec 2016 | $2.28 M(-6.3%) | $516.00 K(-12.1%) | $2.28 M(-2.9%) |
| Sept 2016 | - | $587.00 K(+0.3%) | $2.35 M(+0.2%) |
| June 2016 | - | $585.00 K(-1.0%) | $2.34 M(-1.1%) |
| Mar 2016 | - | $591.00 K(+1.2%) | $2.37 M(-2.6%) |
| Dec 2015 | $2.43 M(+8.2%) | $584.00 K(+0.2%) | $2.43 M(-2.0%) |
| Sept 2015 | - | $583.00 K(-4.7%) | $2.48 M(+0.9%) |
| June 2015 | - | $612.00 K(-6.4%) | $2.46 M(+3.2%) |
| Mar 2015 | - | $654.00 K(+3.3%) | $2.38 M(+6.0%) |
| Dec 2014 | $2.25 M(+10.1%) | $633.00 K(+12.8%) | $2.25 M(+4.8%) |
| Sept 2014 | - | $561.00 K(+4.7%) | $2.15 M(+2.7%) |
| June 2014 | - | $536.00 K(+3.3%) | $2.09 M(+1.7%) |
| Mar 2014 | - | $519.00 K(-2.1%) | $2.06 M(+0.6%) |
| Dec 2013 | $2.04 M(+11.3%) | $530.00 K(+5.0%) | $2.04 M(+35.1%) |
| Sept 2013 | - | $505.00 K(+0.8%) | $1.51 M(+50.1%) |
| June 2013 | - | $501.00 K(-1.0%) | $1.01 M(+99.0%) |
| Mar 2013 | - | $506.00 K | $506.00 K |
| Dec 2012 | $1.83 M(+29.3%) | - | - |
| Dec 2011 | $1.42 M | - | - |
FAQ
- What is Evogene annual depreciation & amortization?
- What is the all time high annual D&A for Evogene?
- What is Evogene annual D&A year-on-year change?
- What is Evogene quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Evogene?
- What is Evogene quarterly D&A year-on-year change?
- What is Evogene TTM depreciation & amortization?
- What is the all time high TTM D&A for Evogene?
- What is Evogene TTM D&A year-on-year change?
What is Evogene annual depreciation & amortization?
The current annual D&A of EVGN is $2.61 M
What is the all time high annual D&A for Evogene?
Evogene all-time high annual depreciation & amortization is $2.77 M
What is Evogene annual D&A year-on-year change?
Over the past year, EVGN annual depreciation & amortization has changed by +$32.00 K (+1.24%)
What is Evogene quarterly depreciation & amortization?
The current quarterly D&A of EVGN is $627.00 K
What is the all time high quarterly D&A for Evogene?
Evogene all-time high quarterly depreciation & amortization is $785.00 K
What is Evogene quarterly D&A year-on-year change?
Over the past year, EVGN quarterly depreciation & amortization has changed by -$34.00 K (-5.14%)
What is Evogene TTM depreciation & amortization?
The current TTM D&A of EVGN is $2.57 M
What is the all time high TTM D&A for Evogene?
Evogene all-time high TTM depreciation & amortization is $2.83 M
What is Evogene TTM D&A year-on-year change?
Over the past year, EVGN TTM depreciation & amortization has changed by -$16.00 K (-0.62%)